Update on Fiasp insulin 17 August 2023 Diabetes Australia have been consistently talking with both the Federal Government and Novo Nordisk about the need for a solution before 1 October 2023. We have been advised that negotiations are continuing. Both the Government and the manufacturer have been made aware of the significant angst this is causing the diabetes community Diabetes Australia will continue to advocate on this issue. We have set up a page – Fight for Fiasp – where you can lend your voice and advocate on this issue. We will keep you updated, as and when we hear anything on this issue.
News 12 December 2024 Expanded access to cheaper medicines for Australians living with type 2 diabetes Diabetes Australia thanks the Albanese Government for its decision to expand the Pharmaceutical Benefits Scheme (PBS) listings for Forxiga® and... Continue Reading
Blog 3 December 2024 Medical device recall: Accu-Chek Spirit 3.15 ml cartridge system There is a potential for insulin leakage with the Accu-Chek Spirit 3.15 ml cartridge system due to a manufacturing problem. Continue Reading
Blog 4 November 2024 Understanding diabetes and its medications Diabetes is a condition that affects some 1.5 million Australians. One of the most important aspects of diabetes is keeping... Continue Reading
